Novel peptides represent the exciting area in drug development. Such brief chains of building acids provide unprecedented potential for engaging difficult processes involved in multiple conditions. Initial studies suggest they can provide specific interaction and exhibit desirable ADME features, opening ways to groundbreaking therapies. Continued a